TrialHepatology international2016

Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin.

Masahiko Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.